Return to Science Search homepage
Return to Project List
|
Evaluating the field efficacy of the fungicide enilconazole (Imazalil) as a potential alternative chemical treatment for the control of Nosema spp. - VM0139
|
Description
There is a need to protect UK honey bee stocks from the threats posed by the microsporidial fungal pathogens, Nosema spp. The antibiotic Fumidil-B (Fumagillin/ bicyclohexylammonium, marketed by Ceva Ltd.) is proven to be effective in controlling Nosemosis caused by both N. apis and Asian variant N. ceranae, but this product is no longer licensed for the treatment of Nosema diseases in the majority of EU member states. Although Fumidil-B is currently still available for use in the UK as the sole chemical treatment of Nosema infection, recent data suggests that it may have carcinogenic properties. In the likely event of the future withdrawal of this product from UK shelves, there is a pressing requirement to identify suitable replacement substances. This project proposes to evaluate the field efficacy of the fungicide enilconazole (trade name Imazalil) as a potential alternative chemical treatment for the control of Nosema spp. |
Project Documents
• EVID4 - Final project report : VM0139 EVID 4 final report
(166k)
|
Time-Scale and Cost
From:
2009
|
To:
2011
|
|
Cost: £45,529 |
|
Contractor / Funded Organisations
Central Science Laboratory |
Keywords
|